Global Markets for Emerging Insulin Drug and Delivery Technologies, with Focus on Syringes and Vials - ResearchAndMarkets.com

18 Mar 2024
www.businesswire.com
DUBLIN--(BUSINESS WIRE)--The "Global Markets for Emerging Insulin Drug and Delivery Technologies: Focus on Syringes and Vials" report has been added to ResearchAndMarkets.com's offering.
'Global Markets for Emerging Insulin Drug and Delivery Technologies: Focus on Syringes and Vials'
The Global Emerging Insulin Drug and Delivery Technologies Market was valued at $55.8 Billion in 2023 and is and is expected to reach $88.9 Billion in 2028, rising at a CAGR of 9.8%.
This report discusses the implications of the growing diabetes epidemic on the global and regional markets for emerging insulin drug and delivery technologies. It discusses companies in the relevant pharmaceutical and medical industries and provides profiles of the leading players as well as an update on M&A activity. The report's patent analysis focuses on developments in Japan, Europe, and the U.S. Five-year global sales forecasts are provided for the major categories of insulin drug and delivery technologies and devices categories.
The Report Includes
57 data tables and 83 additional tables
An overview and industry analysis of the global markets for emerging insulin drug and delivery technologies, with an emphasis on plastic insulin syringes and vials
Analyses of the global market trends, with historical market revenue data (sales figures) for 2020 to 2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
Estimate of the actual market size and revenue growth forecast, and a corresponding market share analysis by product type, application, and region
A look at the emerging technologies that have potential in the diabetes market, with improved glucose control, along with improved delivery methods
Examination of the current state of the insulin drug and delivery industry structure, focusing on technological updates and issues surrounding insulin pens and insulin syringes, ongoing research activities, and regulatory and pricing scenarios
Discussion of market dynamics, clinical trial applications, regulations, and penetration of technologies in the pharmaceutical and biotechnology markets
Discussion of the ESG developments and how they impact corporate performance, ratings and matrices, and consumer attitude, as well as the ESG practices of leading pharma and biotech companies
Review of the key patent grants/publications for insulin as a drug, along with its delivery methods
Analysis of the competitive landscape based on recent developments and segmental revenues of leading companies
Profiles of the leading market players
The analysis revealed that the fastest-growing market segment is smart pens, which is expected to grow at a predicted CAGR of 12.6% during the forecast period. The insulin syringes and vials segment is expected to have the slowest growth rate, a CAGR of 8.7%.
The increase in prevalence of diabetes mellitus, including type 2 diabetes worldwide, the most prevalent form, has reached epidemic levels. Concurrently, instances of type 1 diabetes mellitus are on the rise, albeit to a lesser extent. These escalating trends raise significant alarm, impacting not only those affected but also governments and healthcare providers, as the economic ramifications of diabetes are substantial. They involve the direct burden of managing the disease and its common and often catastrophic complications, including cardiovascular disease, peripheral neuropathy and blindness.
Ensuring timely diagnosis of diabetes and delivering efficient treatment are priorities for governments and healthcare organizations. As the prevalence of diabetes continues to rise and diagnostic methods advance, the existing market for insulin drug and delivery technologies is expected to expand significantly. Consequently, diabetes holds substantial commercial importance for both the manufacturers of treatment drugs and the producers of monitoring devices.
For companies in this sector to strengthen their market position, they require precise and current evaluations of the present magnitude of the diabetes epidemic, as well as its probable trajectory over the upcoming five years, and the potential impact of insulin drug and delivery devices and technical developments now in the pipeline.
The market for insulin drug and delivery technologies will continue to grow significantly in many areas, notably regulatory compliance.
Key Attributes:
Report Attribute
Details
No. of Pages
158
Forecast Period
2023 - 2028
Estimated Market Value (USD) in 2023
$55.8 Billion
Forecasted Market Value (USD) by 2028
$88.9 Billion
Compound Annual Growth Rate
9.8%
Regions Covered
Global
Key Topics Covered:
Chapter 1 Introduction
Chapter 2 Summary and Highlights
Chapter 3 Market Overview
Types of Diabetes
Impaired Glucose Tolerance and Impaired Fasting Glucose
Epidemiology of Diabetes
Gender Distribution
Regional Disparities
Market Dynamics Snapshot
Factors Affecting the Market
Market Drivers
Market Restraints
Chapter 4 Global Market for Emerging Insulin Drug and Delivery Technologies, by Type
Technological Advances in Insulin Syringes
Insulin Delivery Pen Devices
Disposable Insulin Pens
Reusable Insulin Pens
Technological Advances in Insulin Drug and Delivery Pen Devices
External Insulin Pumps
Technological Advances in Insulin Pump Systems
Implantable Insulin Pumps
Closed-Loop Artificial Pancreas
Bionic Pancreas
Smart Pens
Chapter 5 Global Market for Emerging Insulin Drug Delivery Devices, by Application
Chapter 6 Global Market for Insulin Drug Delivery Devices, by Region
Chapter 7 Regulatory Landscape
Chapter 8 Sustainability in the Insulin Drug and Delivery Market: An ESG Perspective
Patient Outcomes Beyond Glucose Control
Chapter 10 Patent Analysis
Chapter 11 M&A and Venture Funding Outlook
Chapter 12 Competitive Landscape
Chapter 13 Company Profiles
B. Braun
BD
Cardinal Health
Diabeloop
Emperra
Lilly
Nugen Medical Devices
Owen Mumford
Ypsomed
For more information about this report visit https://www.researchandmarkets.com/r/8ravs1
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-
Drugs
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.